Colgate-Palmolive Company $CL Shares Purchased by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management increased its Colgate-Palmolive stake by 23.6% in the third quarter, purchasing 689,131 additional shares for a total holding valued at approximately $308.4 million. Institutional investors collectively own 80.41% of the company.
• Colgate-Palmolive reported quarterly EPS of $0.99, beating estimates by $0.04, while revenue reached $5.36 billion, up 4.9% year over year. The company declared a quarterly dividend of $0.53 per share, equivalent to a 2.2% yield.
• Analyst sentiment remains favorable but mixed, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $98.00. Meanwhile, insiders sold approximately $16.1 million worth of shares over the past three months.

Robeco Institutional Asset Management B.V. increased its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 23.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,614,070 shares of the company's stock after purchasing an additional 689,131 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.45% of Colgate-Palmolive worth $308,352,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Virginia Estate & Retirement Planning Advisors Inc. lifted its position in Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company's stock valued at $28,000 after acquiring an additional 310 shares during the last quarter. Parvin Asset Management LLC purchased a new position in Colgate-Palmolive in the second quarter worth $32,000. Park Place Capital Corp increased its position in shares of Colgate-Palmolive by 55.5% during the second quarter. Park Place Capital Corp now owns 356 shares of the company's stock worth $33,000 after purchasing an additional 127 shares in the last quarter. Cherry Tree Wealth Management LLC increased its position in shares of Colgate-Palmolive by 7,840.0% during the second quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock worth $36,000 after purchasing an additional 392 shares in the last quarter. Finally, Montgomery Financial Services LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at $36,000. Institutional investors own 80.41% of the company's stock.

Insider Activity

In other news, Director John Cahill sold 4,170 shares of the stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company's stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer owned 64,901 shares of the company's stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Company insiders own 0.43% of the company's stock.

Colgate-Palmolive Trading Up 1.2%

NYSE:CL opened at $94.47 on Wednesday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a fifty day simple moving average of $89.10 and a 200-day simple moving average of $89.17. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The company has a market capitalization of $75.31 billion, a P/E ratio of 37.49, a PEG ratio of 4.52 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The firm's revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 EPS. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive's payout ratio is presently 84.13%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Bank of America lowered their price objective on Colgate-Palmolive from $102.00 to $100.00 and set a "buy" rating for the company in a research report on Friday, October 9th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $95.00 to $90.00 and set an "equal weight" rating on the stock in a research report on Monday, October 5th. Weiss Ratings lowered Colgate-Palmolive from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, October 2nd. TD Cowen increased their price target on Colgate-Palmolive from $85.00 to $90.00 and gave the company a "hold" rating in a research note on Monday, August 3rd. Finally, Evercore raised their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an "outperform" rating in a report on Thursday, October 8th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.